Assessment of Implantable Cardioverter-Defibrillator Used in Heart Failure with Reduced Ejection Fraction as Primary Prevention in an Underserved Population

被引：0
|
作者：
Lu, Yifan [1 ]
Wan, Ningxin [1 ]
Madan, Nidhi [1 ]
Hovnanians, Ninel [1 ]
Diaz, Juan Carlos Ruiz [1 ]
Christia, Panagiota [1 ]
Faillace, Robert [1 ]
机构：
[1] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10467 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2018年 / 33卷 / 11期
关键词：
THERAPY;
D O I：
10.1007/s11606-018-4544-1
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1854 / 1856
页数：3
相关论文
共 50 条
  • [1] Assessment of Implantable Cardioverter-Defibrillator Used in Heart Failure with Reduced Ejection Fraction as Primary Prevention in an Underserved Population
    Yifan Lu
    Ningxin Wan
    Nidhi Madan
    Ninel Hovnanians
    Juan Carlos Ruiz Diaz
    Panagiota Christia
    Robert Faillace
    Journal of General Internal Medicine, 2018, 33 : 1854 - 1856
  • [2] LOW COMPLIANCE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR USE FOR HEART FAILURE WITH REDUCED EJECTION FRACTION IN AN UNDERSERVED POPULATION
    Lu, Yifan
    Wan, Ningxin
    The Hung Nguyen
    Madan, Nidhi
    Hovnanians, Ninel
    Diaz, Juan Carlos Ruiz
    Holzhauser, Luise
    Grushko, Michael
    Faillace, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 686 - 686
  • [3] Primary Prevention Implantable Cardioverter-Defibrillator Therapy in Heart Failure with Recovered Ejection Fraction
    Baman, Jayson R.
    Patil, Kaustubha D.
    Medhekar, Ankit N.
    Wilcox, Jane E.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 585 - 596
  • [4] Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
    Rorth, Rasmus
    Dewan, Pooja
    Kristensen, Soren Lund
    Jhund, Pardeep S.
    Petrie, Mark C.
    Kober, Lars
    McMurray, John J. V.
    CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (08) : 868 - 877
  • [5] Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
    Rasmus Rørth
    Pooja Dewan
    Søren Lund Kristensen
    Pardeep S. Jhund
    Mark C. Petrie
    Lars Køber
    John J. V. McMurray
    Clinical Research in Cardiology, 2019, 108 : 868 - 877
  • [6] Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?
    Abdelhamid, Magdy
    Rosano, Giuseppe
    Metra, Marco
    Adamopoulos, Stamatis
    Boehm, Michael
    Chioncel, Ovidiu
    Filippatos, Gerasimos
    Jankowska, Ewa A.
    Lopatin, Yury
    Lund, Lars
    Milicic, Davor
    Moura, Brenda
    Ben Gal, Tuvia
    Ristic, Arsen
    Rakisheva, Amina
    Savarese, Gianluigi
    Mullens, Wilfried
    Piepoli, Massimo
    Bayes-Genis, Antoni
    Thum, Thomas
    Anker, Stefan D.
    Seferovic, Petar
    Coats, Andrew J. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1460 - 1466
  • [7] Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction
    Masini, Marta
    Elia, Edoardo
    Vianello, Pier Filippo
    Bertero, Giovanni
    Rossi, Paolo
    Ameri, Pietro
    Chiarella, Francesco
    Brunelli, Claudio
    Porto, Italo
    Sartori, Paolo
    Canepa, Marco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (02) : 118 - 125
  • [8] Publisher Correction to: Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
    Clinical Research in Cardiology, 2020, 109 : 529 - 529
  • [9] Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
    Levy, Wayne C.
    Lee, Kerry L.
    Hellkamp, Anne S.
    Poole, Jeanne E.
    Mozaffarian, Dariush
    Linker, David T.
    Maggioni, Aldo P.
    Anand, Inder
    Poole-Wilson, Philip A.
    Fishbein, Daniel P.
    Johnson, George
    Anderson, Jill
    Mark, Daniel B.
    Bardy, Gust H.
    CIRCULATION, 2009, 120 (10) : 835 - 842
  • [10] Sacubitril/valsartan or an implantable cardioverter-defibrillator in heart failure with reduced ejection fraction patients: a cost-effectiveness analysis
    Zaca, Valerio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (10) : 597 - 605
12345